• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

既往癌症病史预示着鼻咽癌患者更差的生存结局。

Prior cancer history predicts the worse survival of patients with nasopharyngeal carcinoma.

作者信息

Yeh Chien-Fu, Chin Yu-Ching, Huang Wei-Hao, Lan Ming-Ying

机构信息

Department of Otorhinolaryngology-Head and Neck Surgery, Taipei Veterans General Hospital, No. 201, Sec. 2, Shipai Rd., Taipei, 11217, Taiwan.

Department of Otolaryngology, National Yang Ming Chiao Tung University School of Medicine, Taipei, 11221, Taiwan.

出版信息

Eur Arch Otorhinolaryngol. 2022 Nov;279(11):5381-5387. doi: 10.1007/s00405-022-07444-1. Epub 2022 Jun 22.

DOI:10.1007/s00405-022-07444-1
PMID:35731292
Abstract

PURPOSE

Previous cancers can be observed in patients with nasopharyngeal carcinoma (NPC). However, whether prior cancer diagnosis affects survival outcomes remains unknown. This study aimed to explore the impact of prior cancer on the survival of patients with NPC.

METHODS

We retrospectively collected data from 666 NPC patients between 2006 and 2018. The patients in this study were divided into those without prior cancer, with prior head and neck cancer, and prior non-head and neck cancer. The demographic data and survival of these groups were then analyzed. The independent prognostic factors for NPC were determined using multivariate Cox regression analysis.

RESULTS

We identified 25 NPC patients with prior cancer in our case series, most of whom had a history of colorectal cancer. Patients with a history of cancer were older than those without a history of cancer (p = 0.001). In the subgroup analysis stratified by the timing of prior cancer, NPC patients with prior non-head and neck cancer within 24, 36, 60, and 120 months showed worse survival than patients without prior cancer (all p < 0.05). When stratified by cancer stage, stage III NPC patients with prior non-head and neck cancer showed worse survival than patients without prior cancer (p < 0.001). Prior cancer and diabetes can predict worse survival in patients with stage III NPC.

CONCLUSION

This study demonstrated that prior cancer and diabetes are independent prognostic factors in patients with stage III NPC.

摘要

目的

在鼻咽癌(NPC)患者中可观察到既往患癌情况。然而,既往癌症诊断是否会影响生存结局仍不清楚。本研究旨在探讨既往癌症对NPC患者生存的影响。

方法

我们回顾性收集了2006年至2018年间666例NPC患者的数据。本研究中的患者被分为无既往癌症、有既往头颈癌和有既往非头颈癌患者。然后分析这些组的人口统计学数据和生存情况。使用多因素Cox回归分析确定NPC的独立预后因素。

结果

在我们的病例系列中,我们确定了25例有既往癌症的NPC患者,其中大多数有结直肠癌病史。有癌症病史的患者比无癌症病史的患者年龄更大(p = 0.001)。在按既往癌症发生时间分层的亚组分析中,在24、36、60和120个月内有既往非头颈癌的NPC患者的生存情况比无既往癌症的患者更差(所有p < 0.05)。按癌症分期分层时,有既往非头颈癌的III期NPC患者的生存情况比无既往癌症的患者更差(p < 0.001)。既往癌症和糖尿病可预测III期NPC患者的生存情况更差。

结论

本研究表明,既往癌症和糖尿病是III期NPC患者的独立预后因素。

相似文献

1
Prior cancer history predicts the worse survival of patients with nasopharyngeal carcinoma.既往癌症病史预示着鼻咽癌患者更差的生存结局。
Eur Arch Otorhinolaryngol. 2022 Nov;279(11):5381-5387. doi: 10.1007/s00405-022-07444-1. Epub 2022 Jun 22.
2
Histological subtype remains a prognostic factor for survival in nasopharyngeal carcinoma patients.组织学亚型仍然是鼻咽癌患者生存的预后因素。
Laryngoscope. 2020 Mar;130(3):E83-E88. doi: 10.1002/lary.28099. Epub 2019 Jun 12.
3
Can neoadjuvant chemotherapy improve survival in stage T3-4N1 nasopharyngeal carcinoma? A propensity matched analysis.新辅助化疗能否提高 T3-4N1 期鼻咽癌患者的生存率?一项倾向评分匹配分析。
Radiat Oncol. 2020 Jul 2;15(1):160. doi: 10.1186/s13014-020-01594-4.
4
Efficacy of chemoradiotherapy in survival of stage Ⅳ nasopharyngeal carcinoma and establishment of a prognostic model.放化疗对Ⅳ期鼻咽癌生存的疗效及预后模型的建立。
Oral Oncol. 2022 Aug;131:105927. doi: 10.1016/j.oraloncology.2022.105927. Epub 2022 Jun 6.
5
Prognostic factors of nasopharyngeal carcinoma patients in a tertiary referral hospital: a retrospective cohort study.一家三级转诊医院鼻咽癌患者的预后因素:一项回顾性队列研究。
BMC Res Notes. 2017 Dec 6;10(1):705. doi: 10.1186/s13104-017-2990-1.
6
Survival among subgroups of patients with stage II nasopharyngeal carcinoma.Ⅱ期鼻咽癌患者亚组的生存情况。
Sci Rep. 2022 Apr 29;12(1):7007. doi: 10.1038/s41598-022-11145-4.
7
Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.整合模型纳入转移性区域颈淋巴结体积和治疗前血清爱泼斯坦-巴尔病毒DNA拷贝数在预测N1期鼻咽癌患者远处转移中的预后价值
Chin J Cancer. 2017 Dec 29;36(1):98. doi: 10.1186/s40880-017-0264-x.
8
Surgery for isolated regional failure in nasopharyngeal carcinoma after radiation: Selective or comprehensive neck dissection.鼻咽癌放疗后孤立区域失败的手术治疗:选择性或根治性颈淋巴结清扫术
Laryngoscope. 2019 Feb;129(2):387-395. doi: 10.1002/lary.27317. Epub 2018 Oct 16.
9
Serum ferritin predicted prognosis in patients with nasopharyngeal carcinoma.血清铁蛋白可预测鼻咽癌患者的预后。
Sci Rep. 2024 Feb 21;14(1):4311. doi: 10.1038/s41598-024-54627-3.
10
Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.提出的修改和纳入血浆 Epstein-Barr 病毒 DNA 可改善与 Epstein-Barr 病毒相关的鼻咽癌的 TNM 分期系统。
Cancer. 2019 Jan 1;125(1):79-89. doi: 10.1002/cncr.31741. Epub 2018 Oct 23.

引用本文的文献

1
Clinical and survival differences between second primary and first primary nasopharyngeal carcinoma in a retrospective study.一项回顾性研究中第二原发性与第一原发性鼻咽癌的临床及生存差异
Discov Oncol. 2025 Aug 12;16(1):1538. doi: 10.1007/s12672-025-03250-3.
2
MUC5B regulates alterations in the immune microenvironment in nasopharyngeal carcinoma via the Wnt/β-catenin signaling pathway.MUC5B通过Wnt/β-连环蛋白信号通路调节鼻咽癌免疫微环境的改变。
Discov Oncol. 2025 Jan 9;16(1):27. doi: 10.1007/s12672-025-01772-4.
3
Impact of prior cancer history on the prognosis of extranodal NK/T-cell lymphoma.

本文引用的文献

1
The role of nasopharyngectomy in the management of nasopharyngeal carcinoma.鼻咽癌切除术在鼻咽癌治疗中的作用。
Curr Opin Otolaryngol Head Neck Surg. 2022 Feb 1;30(1):3-12. doi: 10.1097/MOO.0000000000000780.
2
Impact of prior cancer history on the survival of patients with larynx cancer.既往癌症史对喉癌患者生存的影响。
BMC Cancer. 2020 Nov 23;20(1):1137. doi: 10.1186/s12885-020-07634-2.
3
Impact of prior cancer history on the overall survival of younger patients with lung cancer.既往癌症史对年轻肺癌患者总生存的影响。
既往癌症史对结外 NK/T 细胞淋巴瘤预后的影响。
PLoS One. 2024 Oct 16;19(10):e0311094. doi: 10.1371/journal.pone.0311094. eCollection 2024.
ESMO Open. 2020 Feb;5(1). doi: 10.1136/esmoopen-2019-000608.
4
Prognostic model and optimal treatment for patients with stage IVc nasopharyngeal carcinoma at diagnosis.诊断时 IVc 期鼻咽癌患者的预后模型和最佳治疗方案。
Sci Rep. 2019 Dec 17;9(1):19272. doi: 10.1038/s41598-019-55586-w.
5
Impact of prior cancer on outcomes in nasopharyngeal carcinoma.既往癌症对鼻咽癌预后的影响。
Ann Transl Med. 2019 Jul;7(14):299. doi: 10.21037/atm.2019.05.78.
6
Nasopharyngeal carcinoma.鼻咽癌。
Lancet. 2019 Jul 6;394(10192):64-80. doi: 10.1016/S0140-6736(19)30956-0. Epub 2019 Jun 6.
7
Effect of prior cancer on trial eligibility and treatment outcomes in nasopharyngeal carcinoma: Implications for clinical trial accrual.先前癌症对鼻咽癌临床试验入选和治疗结果的影响:对临床试验入组的影响。
Oral Oncol. 2019 Mar;90:23-29. doi: 10.1016/j.oraloncology.2019.01.023. Epub 2019 Feb 1.
8
Long-term survival and late complications of intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.调强放疗治疗复发性鼻咽癌的长期生存和晚期并发症。
BMC Cancer. 2018 Nov 20;18(1):1139. doi: 10.1186/s12885-018-5055-5.
9
Impact of prior cancer history on the overall survival of patients newly diagnosed with cancer: A pan-cancer analysis of the SEER database.既往癌症史对新发癌症患者总生存的影响:SEER 数据库泛癌症分析。
Int J Cancer. 2018 Oct 1;143(7):1569-1577. doi: 10.1002/ijc.31543. Epub 2018 May 7.
10
Impact of diabetes mellitus on the risk and survival of nasopharyngeal carcinoma: a meta-analysis.糖尿病对鼻咽癌风险及生存的影响:一项荟萃分析
Onco Targets Ther. 2018 Mar 2;11:1193-1201. doi: 10.2147/OTT.S152217. eCollection 2018.